ID
41569
Beschreibung
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Randomisation, Run-in Failure) is to be filled out at Visit 2 (Randomisation).
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Stichworte
Versionen (1)
- 11.11.20 11.11.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
11. November 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Randomisation, Run-in Failure
- StudyEvent: ODM
Beschreibung
Randomisation number
Alias
- UMLS CUI-1
- C0034656
- UMLS CUI-2
- C0237753
Beschreibung
Run-in Failure
Alias
- UMLS CUI-1
- C1710476
Beschreibung
Run-in Failure
Datentyp
text
Alias
- UMLS CUI [1]
- C1710476
Beschreibung
Date is optional and should be removed from the prompt when date is not being captured.
Datentyp
date
Alias
- UMLS CUI [1,1]
- C1710476
- UMLS CUI [1,2]
- C0011008
Beschreibung
Primary reason for run-in failure
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1710476
- UMLS CUI [1,2]
- C0566251
Beschreibung
Primary reason for run-in failure: Adverse Event, COPD exacerbation under investigation
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1710476
- UMLS CUI [1,2]
- C0877248
- UMLS CUI [1,3]
- C0566251
- UMLS CUI [2,1]
- C1261322
- UMLS CUI [2,2]
- C0740304
Beschreibung
Primary reason for run-in failure: Investigator discretion
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1710476
- UMLS CUI [1,2]
- C0566251
- UMLS CUI [1,3]
- C0008961
- UMLS CUI [1,4]
- C0022423
Ähnliche Modelle
Randomisation, Run-in Failure
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0332149 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C1261322 (UMLS CUI [2,1])
C0740304 (UMLS CUI [2,2])
C0566251 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])